0001838748-21-000002.txt : 20211119 0001838748-21-000002.hdr.sgml : 20211119 20211119161830 ACCESSION NUMBER: 0001838748-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211119 DATE AS OF CHANGE: 20211119 EFFECTIVENESS DATE: 20211119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Endogena Therapeutics, Inc. CENTRAL INDEX KEY: 0001838748 IRS NUMBER: 813692564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-421883 FILM NUMBER: 211428538 BUSINESS ADDRESS: STREET 1: 111 PINE STREET STREET 2: SUITE 1410 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-433-2262 MAIL ADDRESS: STREET 1: 111 PINE STREET STREET 2: SUITE 1410 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 D 1 primary_doc.xml X0708 D LIVE 0001838748 Endogena Therapeutics, Inc. 111 PINE STREET SUITE 1410 SAN FRANCISCO CA CALIFORNIA 94111 415-433-2262 DELAWARE None None Corporation true Matthias Steger c/o Endogena Therapeutics, Inc. 111 Pine Street, Suite 1410 San Francisco CA CALIFORNIA 94111 Executive Officer Director Aaron Weaver c/o Endogena Therapeutics, Inc. 111 Pine Street, Suite 1410 San Francisco CA CALIFORNIA 94111 Director Elona Baum c/o Endogena Therapeutics, Inc. 111 Pine Street, Suite 1410 San Francisco CA CALIFORNIA 94111 Director Daniel Zabrowski c/o Endogena Therapeutics, Inc. 111 Pine Street, Suite 1410 San Francisco CA CALIFORNIA 94111 Director Markus Bertini c/o Endogena Therapeutics, Inc. 111 Pine Street, Suite 1410 San Francisco CA CALIFORNIA 94111 Executive Officer Other Decline to Disclose 06b false 2021-11-04 false true false 0 24999999 7346961 17653038 false 12 0 0 0 false Endogena Therapeutics, Inc. /s/Matthias Steger Matthias Steger President 2021-11-18